April 27-28, 2017 | Bethesda North Marriott Hotel & Conference Center
Department of Commerce: The Maryland Department of Commerce stimulates private investment and creates jobs by attracting new businesses, encouraging the expansion and retention of existing companies, and providing financial assistance to Maryland companies. The Department promotes the State’s many economic advantages and markets local products and services at home and abroad to spur economic development and international investment, trade and tourism. Because they are major economic generators, the Department also supports the Arts, film production, sports and other special events. For more information, visit commerce.maryland.gov
Alexandria Real Estate: Alexandria Real Estate Equities, Inc. (NYSE:ARE) is the largest and leading office REIT uniquely focused on collaborative science and technology campuses in AAA innovation cluster locations, including Greater Boston, San Francisco, New York City, San Diego, Seattle, Maryland, and Research Triangle Park. Alexandria has a longstanding and proven track record of developing Class A assets clustered in urban science and technology campuses that provide its innovative tenants with highly dynamic and collaborative environments that enhance their ability to successfully recruit and retain world-class talent and inspire productivity, efficiency, creativity, and success. For additional information on Alexandria, please visit www.are.com.
KAI Research: KAI Research, Inc. operates as a clinical research organization (CRO). It focuses on providing various services, including clinical studies support, clinical data management systems, pharmacovigilance and clinical safety, medical communications, data warehousing, statistical analysis and SAS programming, quality assurance, and registries. The company provides CRO services for phase I-IV clinical trials and epidemiological studies in various therapeutic areas, including CNS, dermatology, endocrinology, infectious diseases, pain, psychiatric disorders, rheumatology, substance abuse, and vaccines. It also offers a suite of clinical trial systems, including an electronic data capture system; an interactive voice response and interactive Web response system; a clinical trial management system that focuses on the operational side of the trial, including site performance tracking and management, patient recruitment, monitoring visit report, regulatory document management, and financial management; and a medical coding system that provides medical reviewers with a task-oriented coding tool for adverse events and drugs. The company was founded in 1986 and is based in Rockville, Maryland. For more information, visit www.kai-research.com
AstraZeneca/MedImmune: MedImmune is the global biologics research and develoment arm of AstraZeneca. MedImmune is pioneering innovative research and exploring novel pathways across key therapeutic areas, including respiratory, inflammation and autoimmunity; cardiovascular and metabolic disease; oncology; neuroscience; and infection and vaccines. The MedImmune headquarters is located in Gaithersburg, Md., one of AstraZeneca’s three global R&D centers. For more information, please visit www.medimmune.com.